AbClon
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability, and Efficacy of AT101 in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma (NCT05338931) | AbClon | 2022-03-15 |
Track AbClon automatically
Every clearance here is in the API, with alerts when new ones post.